undamentalytics Newsletter

Myomo, Inc. insider trading

Every open-market purchase and sale by Myomo, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

Insider purchase Insider sale Marker size reflects trade value. Weekly closes adjusted for splits; may be delayed.
Myomo, Inc. insider open-market trades
DateInsiderTrade SharesPriceValue 1M after 3M after 6M after

From insiders' Form 4 filings with the SEC: open-market purchases and sales only (awards, option exercises and shares withheld for tax are excluded), combined to one line per insider per day. "Plan" marks trades the filing says were made under a pre-set Rule 10b5-1 trading plan, which are scheduled in advance. Price changes run from the close on the trade date; hover a figure for the change relative to the S&P 500. Past moves don't predict future ones.

Does following Myomo, Inc.’s insiders pay?

From February 14, 2020 to October 15, 2026, 9 insiders reported 28 open-market purchases and 12 sales not made under a pre-set plan in Myomo, Inc. Twelve months after each purchase was reported, the shares were +70.7% against the S&P 500 on average (median +85.3%), over 5 purchases with a full year of prices; 60% beat the index. After sales, the shares moved −105.7% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on February 18, 2020 into $4,881 by November 2, 2026, −10.2% a year. It held shares 45% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $20,499 (+11.3% a year), and held throughout $24,708 (+14.5%).

$0$10.0k$20.0k$30.0k 2020202120222023202420252026 $24.7k$20.5k$4.9k
Copying Myomo, Inc.'s insidersS&P 500, same days investedS&P 500, held throughout $10,000 copying every open-market purchase by Myomo, Inc.'s insiders from February 18, 2020, before costs and taxes, marked weekly. Uninvested money earns the Treasury bill rate; the portfolio held shares 45% of the time.
Myomo, Inc.: each insider's record
InsiderRolePurchases12 months after their purchasesBeat the S&P 500Sales12 months after their salesLatest report
Kirk Thomas F Director 13 −11.2% (3) 33% 0 — June 9, 2026
Gudonis Paul R Chief Executive Officer 8 +193.4% (1) 100% 0 — August 18, 2025
Kovelman Harry Chief Medical Officer 0 — — 7 −106.7% (1) October 15, 2026
Henry David A Chief Financial Officer 3 +193.4% (1) 100% 0 — August 30, 2023
Crowley Thomas Aloysius JR. Director 0 — — 2 — June 30, 2023
Getz Heather C Director 2 — — 0 — March 17, 2026
Mitchell Micah Chief Commercial Officer 0 — — 2 −104.7% (1) May 15, 2026
Morris Milton Mayo Director 1 — — 1 — September 4, 2026
Manko Joseph M. JR. Director 1 — — 0 — May 18, 2026

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

← Back to Myomo, Inc. · Funds · Politicians